Active ingredientGadoxetate Disodium Salt (Mixture of Diastereomers)Cat. No. P-G009-001CAS 135326-22-6Family · Pharmaceutical analytical standards
Gadoxetate
A liver-specific gadolinium-based contrast agent, approved in Europe in the mid-2000s and in the United States in 2008: in magnetic resonance imaging it helps detect and characterise liver lesions. This family brings together the active ingredient and other impurities.
Did you know?About half of the dose is eliminated by the liver, which actively secretes it into bile, and the other half by the kidneys: this is why healthy liver tissue appears brighter on the images.
Go to the active ingredient →Active ingredientGadoxetate Disodium Salt (Mixture of Diastereomers)Cat. No. P-G009-001CAS 135326-22-6
Impurity(R)-EOB-DTPACat. No. P-G009-002CAS 158599-73-6
ImpurityGadoxetate Impurity 1 (Mixture of Diastereomers)Cat. No. P-G009-004CAS 158703-75-4
ImpurityGadoxetate Impurity 2Cat. No. P-G009-005CAS 158599-72-5
ImpurityGadoxetate Impurity 3Cat. No. P-G009-006
ImpurityGadoxetate Impurity 4Cat. No. P-G009-007
ImpurityGadoxetate Impurity 5Cat. No. P-G009-008CAS 689213-98-7
ImpurityGadoxetate Impurity 6Cat. No. P-G009-009CAS 206987-58-8
ImpurityGadoxetate Impurity 7Cat. No. P-G009-010
ImpurityGadoxetate Impurity 8Cat. No. P-G009-011No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.